Abstract
Objectives: Metastatic melanoma (MM) is a leading cause of years of life lost due to malignancy. This study aimed to identify the average years of life lost (AYLL) in MM patients. Methods: MM patients were identified from a prospectively maintained database, and a linear model predicting AYLL was developed. Results: Between 1970 and 1999, 4,774 patients diagnosed with MM died. The AYLL was 23.2 years. AYLL remained stable across three decades. Conclusions: AYLL for MM is greater than 20 years, and has not improved. This burden underscores the need for continued research and access to funding for this disease.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 637-641 |
| Number of pages | 5 |
| Journal | Cancer Investigation |
| Volume | 30 |
| Issue number | 9 |
| DOIs | |
| State | Published - Nov 2012 |
| Externally published | Yes |
Fingerprint
Keywords
- Life expectancy
- Melanoma
- Mortality
- Potential years of life lost
- Survival
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma : Contemporary estimates of average years of life lost. / Salama, April K S; Rosa, Nicole De; Scheri, Randall P.; Herndon, James E.; Tyler, Douglas; Marcello, Jennifer; Pruitt, Scott K.; Abernethy, Amy P.
In: Cancer Investigation, Vol. 30, No. 9, 11.2012, p. 637-641.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma
T2 - Contemporary estimates of average years of life lost
AU - Salama, April K S
AU - Rosa, Nicole De
AU - Scheri, Randall P.
AU - Herndon, James E.
AU - Tyler, Douglas
AU - Marcello, Jennifer
AU - Pruitt, Scott K.
AU - Abernethy, Amy P.
PY - 2012/11
Y1 - 2012/11
N2 - Objectives: Metastatic melanoma (MM) is a leading cause of years of life lost due to malignancy. This study aimed to identify the average years of life lost (AYLL) in MM patients. Methods: MM patients were identified from a prospectively maintained database, and a linear model predicting AYLL was developed. Results: Between 1970 and 1999, 4,774 patients diagnosed with MM died. The AYLL was 23.2 years. AYLL remained stable across three decades. Conclusions: AYLL for MM is greater than 20 years, and has not improved. This burden underscores the need for continued research and access to funding for this disease.
AB - Objectives: Metastatic melanoma (MM) is a leading cause of years of life lost due to malignancy. This study aimed to identify the average years of life lost (AYLL) in MM patients. Methods: MM patients were identified from a prospectively maintained database, and a linear model predicting AYLL was developed. Results: Between 1970 and 1999, 4,774 patients diagnosed with MM died. The AYLL was 23.2 years. AYLL remained stable across three decades. Conclusions: AYLL for MM is greater than 20 years, and has not improved. This burden underscores the need for continued research and access to funding for this disease.
KW - Life expectancy
KW - Melanoma
KW - Mortality
KW - Potential years of life lost
KW - Survival
UR - http://www.scopus.com/inward/record.url?scp=84867721516&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84867721516&partnerID=8YFLogxK
U2 - 10.3109/07357907.2012.726387
DO - 10.3109/07357907.2012.726387
M3 - Article
VL - 30
SP - 637
EP - 641
JO - Cancer Investigation
JF - Cancer Investigation
SN - 0735-7907
IS - 9
ER -